Wireframe DNA Origami for the Cellular Delivery of Platinum(II)-Based Drugs

Area of Science:

• Nanotechnology
• Biomedical Engineering
• Cancer Therapeutics

Background:

• DNA origami offers customizable nanostructures for drug delivery.
• Platinum-based drugs like cisplatin and phenanthriplatin show promise in cancer treatment.
• Phenanthriplatin exhibits antitumor properties by inhibiting DNA transcription.

Purpose of the Study:

• To investigate wireframe DNA origami as carriers for platinum compounds (cisplatin and phenanthriplatin) in cancer therapy.
• To explore the assembly, platinum loading, stability, and cytotoxicity of these nanocarriers.

Main Methods:

• Assembly of wireframe DNA origami nanostructures.
• Loading of platinum compounds onto the nanostructures.
• Assessment of platinum loading capacity and nanostructure stability.
• Evaluation of cytotoxicity in various cancer cell lines, including MCF-7.

Main Results:

• Ball-like DNA origami nanostructures loaded with phenanthriplatin demonstrated significant cytotoxicity.
• Reduced cell viability to 33% in MCF-7 (cisplatin-resistant breast adenocarcinoma) cells.
• Nanostructures were ineffective against other tested cancer cell lines.

Conclusions:

• Wireframe DNA origami shows potential as a stable carrier for platinum species in cancer therapy.
• The nanocarrier system offers possibilities for long-term drug release.
• Specific drug-loaded nanostructures exhibit targeted cytotoxicity in resistant cancer cells.